The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide

OBJECTIVES: To investigate the clinical characteristics, adverse drug reactions, and outcomes of the oldest old patients (aged ≥80 years) with tuberculosis (TB) treated with rifampicin, isoniazid, and pyrazinamide (RIP)-containing regimens. DESIGN: A retrospective chart review study. SETTING: A 1,20...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Huang-Shen, Cheng, Chun-Wen, Lin, Ming-Shyan, Chou, Yen-Li, Chang, Pey-Jium, Lin, Jing-Chi, Ye, Jung-Jr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795580/
https://www.ncbi.nlm.nih.gov/pubmed/27042029
http://dx.doi.org/10.2147/CIA.S95411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795580/
https://www.ncbi.nlm.nih.gov/pubmed/27042029
http://dx.doi.org/10.2147/CIA.S95411

Ejemplares similares